Express Pharma

JANUARY 13, 2025

This potential was acknowledged by the pharmaceutical industry professionals in a survey* conducted by GlobalData. In the same survey, pharmaceutical industry professionals identified lead generation and optimisation in drug discovery as the area in which AI has been most effectively integrated so far.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

STAT

MARCH 13, 2025

 The questions to telehealth companies highlight the regulatory gray area created when virtual care providers market specific drugs. Telehealth companies that prescribe a range of medications have not been held to the same standards.  Dick Durbin (D-Ill.)   The U.S.

Pharmaceutical Manufacturing 146

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 146

Express Pharma

FEBRUARY 9, 2025

In October 2024, the programme entered a strategic commercial partnership with Sun Pharma, a leading multinational pharmaceutical company. Key study readouts for Phase III FIBROSARC and Phase II FLASH are expected between March and June 2025. The study is expected to complete enrollment between Q4 2025 and Q1 2026.

Pharmaceutical Companies 66

Pharmaceutical Companies Pharmaceutical Companies 66

pharmaphorum

JUNE 12, 2025

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Health and Personal Care Stores 59

Health and Personal Care Stores Diabetes Pharmaceutical Companies Pharmaceutical Companies 59

NY Times

JUNE 11, 2025

Opinion Supported by SKIP ADVERTISEMENT Guest Essay It’s Code Red for Vaccines June 11, 2025, 5:03 a.m. This is despite promising early data on the effectiveness of the company’s bird flu vaccine, and an urgent need for more pandemic response tools. When we have confirmed access, the full article content will load.

Vaccines 126

Vaccines Immunity Immunization Pharmaceutical Companies 126

Express Pharma

FEBRUARY 9, 2025

Alkem Laboratories, an Indian pharmaceutical company, has announced two strategic acquisitions aimed at strengthening its position in the domestic market. The company has signed a binding term sheet to acquire a 100 per cent stake in Adroit Biomed, a company focused on the skincare segment, for approximately INR 140 crore.

Pharmaceutical Companies 66

Pharmaceutical Companies Pharmaceutical Companies 66

Express Pharma

MARCH 16, 2025

In India, pharmaceutical companies responded to global environmental concerns and government mandates by adopting greener manufacturing techniques. Indian pharmaceutical companies have specialised in reverse-engineering complex medicines and producing biosimilars as alternatives to costly biologics.

Biosimilars 110

Biosimilars Insurance Coverage and Processing Pharmaceutical Companies Pharmaceutical Companies 110

Express Pharma

DECEMBER 30, 2024

They also discussed the increasing global emphasis on traceability and the tracking of recall effectiveness, which would require pharmaceutical companies to have detailed documentation of all affected products and batches. The post FOPE & PharmaState Academy host Session 12 of the PULSE series appeared first on Express Pharma.

Documentation 105

Documentation Communication Packaging Pharmaceutical Companies 105

Drug Patent Watch

MARCH 18, 2025

billion by 2025, with a compound annual growth rate (CAGR) of 10.5%. One company that stands out is R-Pharm, a leading Russian pharmaceutical company that has been at the forefront of innovation in the country. billion by 2025, with a CAGR of 10.5%. So, who are the key players in the Russian pharma industry?

Biosimilars 87

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Compounding 87

Pharma Marketing Network

MAY 1, 2025

Introduction In the rapidly evolving pharmaceutical landscape, staying abreast of emerging pharma trends is crucial for maintaining a competitive edge. As we navigate through 2025, several key developments are reshaping the industry, from technological advancements to regulatory reforms. Disclaimer: This content is not medical advice.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

APRIL 8, 2025

To address growing demand from the pharmaceutical industry, Asahi Kasei has launched a new division, Asahi Kasei Life Science, effective from 1 April 2025. The new structure is designed to unify its bioprocess businesses and streamline services offered to pharmaceutical partners across drug development and manufacturing.

Pharmaceutical Manufacturing 76

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies Drug Development 76

Pharma Marketing Network

MAY 4, 2025

As 2025 unfolds, the stakes for pharmaceutical companies continue to rise. In short, pharma market research in 2025 is no longer reactive. In 2025, AI is at the core of how pharma market research functions. Pairing this with real-time analytics gives companies a 360-degree view of the market landscape.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Mirror

FEBRUARY 21, 2025

Effective and accurate candidate molecule screening and optimization has become one of the primary challenges for pharmaceutical companies. It is no secret that the complexities associated with biopharmaceuticals are ever increasing, particularly regarding the development of antibody therapeutics.

Customer Service 52

Customer Service Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

Pharma Marketing Network

OCTOBER 17, 2024

In an increasingly competitive pharmaceutical landscape, the significance of healthcare branding has never been more pronounced. As we approach 2025, the ability of pharmaceutical companies to effectively craft and communicate their brand identity will play a pivotal role in determining their market success.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

Express Pharma

FEBRUARY 17, 2025

Generative AI (GenAI) is being integrated into India’s pharmaceutical and healthcare sectors, according to EYs report, How much productivity can GenAI unlock in India? The AIdea of India: 2025. GenAI is being applied to multiple functions in pharmaceutical companies.

Documentation 71

Documentation Customer Service Pharmaceutical Companies Pharmaceutical Companies 71

Express Pharma

JANUARY 24, 2025

In a notification issued earlier this month, The Union Health Ministry has granted a one-year extension to small and medium-sized pharmaceutical companies to upgrade their facilities as per the revised Schedule M of the Drugs and Cosmetic Act.

Communication 99

Communication Pharmaceutical Companies Pharmaceutical Companies 99

European Pharmaceutical Review

FEBRUARY 13, 2025

Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.

Pharmaceutical Manufacturing 59

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 59

Pharma Marketing Network

APRIL 16, 2025

Thats the promise of data-driven marketing , a strategy thats rapidly transforming how pharmaceutical companies approach promotion, education, and engagement in 2025. Traditionally, pharmaceutical marketing relied on broad segmentation and static content. But in 2025, it’s about personalization at scale.

HIPAA 59

HIPAA Documentation Pharmaceutical Companies Pharmaceutical Companies 59

European Pharmaceutical Review

NOVEMBER 1, 2024

The worldwide pharmaceutical container packaging market is expected to rise in revenue from $104.12 billion in 2025 to approximately $174.45 As pharmaceutical companies are making investments in sustainable packaging this is also driving demand in this market, based on analysis of the study’s findings.

Packaging 52

Packaging Dosage Labelling Pharmaceutical Companies 52

Pharma Marketing Network

JANUARY 7, 2025

In 2025, pharma marketing news is filled with innovation, disruption, and opportunities to grow your business. Digital Dominance in Pharma Marketing The digital revolution has officially taken over the pharmaceutical industry, and theres no turning back. What are the biggest challenges in pharma marketing in 2025?

HIPAA 52

HIPAA Communication Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JUNE 10, 2025

Skip to main content Tuesday 10 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 85

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 85

Pharma Marketing Network

OCTOBER 17, 2024

As we approach 2025, the pharmaceutical industry is witnessing a seismic shift in marketing strategies, driven by technological advancements and evolving consumer expectations. With the increasing digitization of healthcare, pharmaceutical companies are leveraging digital platforms to reach broader audiences more effectively.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Scheduling Appointments 52

European Pharmaceutical Review

JUNE 10, 2024

The company hopes to produce this number tenfold by the end of 2030. Radioligand therapy developments in 2023 and 2024 Other companies making progress producing radioligand therapies include Novartis. In January 2024, the pharmaceutical company obtained manufacturing authorisation for its largest radioligand therapy facility.

Pharmaceutical Manufacturing 98

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 98

FDA Law Blog: Biosimilars

MARCH 18, 2025

On March 13, 2025, the Federal Circuit ventured into the world of reissued patents and PTE. ( Specifically, the Court focused on the purpose: to compensate pharmaceutical companies for the effective truncation of their patent terms while waiting for regulatory approval of new drug applications. In Merck Sharp & Dohme Corp.

Drug Pricing 59

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 59

European Pharmaceutical Review

FEBRUARY 27, 2024

At the time of the announcement, the pharmaceutical company shared that the first Stelara biosimilars are expected to enter the US market in 2025. The post Amgen opens its most advanced manufacturing facility to date appeared first on European Pharmaceutical Review.

Biosimilars 105

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Drug Development 105

Pharmaceutical Technology

JUNE 7, 2023

Eli Lilly has achieved significant gains in the past quarter, leading to it becoming the most valuable pharmaceutical company in the world, with a market cap of $420bn, surpassing Johnson & Johnson.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Labelling Diabetes 98

Pharma Marketing Network

MAY 23, 2025

In 2025, artificial intelligence is helping pharmaceutical brands bridge the gap between regulatory precision and meaningful engagement. In 2025, AI is helping medical affairs teams streamline global content review by auto-tagging references, linking claims to citations, and maintaining audit trails.

Documentation 64

Documentation Communication Pharmaceutical Companies Pharmaceutical Companies 64

European Pharmaceutical Review

MARCH 27, 2025

As scientific and pharmaceutical companies grapple to secure the worlds best talent, the science and immigration sectors are aware that the UKs ability to attract global talent in science and technology is constantly under question. 1 Figure 1 : Costs for UK skilled worker visa compared to those of other leading science nations.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling 52

European Pharmaceutical Review

OCTOBER 6, 2023

There are several benefits of the combination vaccine as a preventative measure against these respiratory conditions, according to the pharmaceutical company. The company reported that a Phase III trial of mRNA-1083 for adults 50 years old and over is set to begin in 2023.

Vaccines 105

Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

European Pharmaceutical Review

AUGUST 1, 2022

The DDiCT initiative aligns with the pharmaceutical company’s broader diversity and inclusion goals for 2020-2025, which aim to address health disparities, clinical trial diversity, supplier diversity, employee giving and workforce representation. Efforts to improve clinical trial diversity are ongoing.

Drug Development 122

Drug Development Pharmaceutical Companies Pharmaceutical Companies 122

European Pharmaceutical Review

MARCH 11, 2025

Newly released Phase III data illustrate potential of three drugs being investigated as treatments for plaque psoriasisnamely two monoclonal antibodies and an oral peptide, from pharmaceutical companies Biocon Biologics, UCB and Johnson & Johnson, respectively.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Marketing Network

DECEMBER 17, 2021

The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size. About 80% of pharmaceutical companies have announced a commitment to becoming carbon-neutral or made a net-zero pledge for carbon emissions. Health for Humanity 2025 Goals.

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies Communication 103

Pharmaceutical Business Review

OCTOBER 22, 2024

This latest agreement took Samsung Biologics’ accumulated contracts for this year to over $3.3bn, the company noted. Samsung Biologics president and CEO John Rim said: “We are pleased to strategically collaborate with the Asia-based pharmaceutical company to bring effective, high-quality biopharmaceuticals to the global market.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Mirror

SEPTEMBER 8, 2021

Marseille, France, Provepharm Life Solutions, a private French pharmaceutical company that finds new applications for well-known molecules, today announces a €120 million ($142.3M) strategic funding. This includes. The post Provepharm Life Solutions raises €120 million appeared first on Pharma Mirror Magazine.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Marketing Network

APRIL 17, 2025

For many pharmaceutical companies in 2025, the answer is clear: pivot aggressively toward digital. With geopolitical volatility sparking new tariff threats and mounting legislative scrutiny over pharmaceutical television ads, pharma digital ad spend is experiencing a noticeable surge.

HIPAA 59

HIPAA Drug Pricing Compounding Pharmaceutical Companies 59

Pharmaceutical Technology

JUNE 6, 2025

Robert Barrie June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook US health secretary Robert F Kennedy Jr. In one of the fierier remarks from the roundtable, RFK Jr said: “At every level, doctors, other providers, our hospitals, the pharmaceutical companies, the insurance companies, all make money by keeping us sick.

Insurance Coverage and Processing 81

Insurance Coverage and Processing Communication Hospitals Drug Development 81

Pharma Marketing Network

JUNE 5, 2025

In the ever-evolving pharmaceutical industry, advertising plays a crucial role in bridging the gap between pharmaceutical companies and healthcare professionals, as well as consumers. So, what are the strongest forms of traditional advertising in pharma, and why do they still matter in 2025?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Hospitals 52